Bioavailability enhancement delivery composition
US9044394B2 · kind B2 · utility
0Cited by
4References
1Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Nov 30, 2011 |
| Grant date | Jun 2, 2015 |
| Priority date | — |
| Expiry date | Nov 30, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/44
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A composition for increasing the bioavailability of an active pharmaceutical ingredient (“API”) in humans and animals, comprising a first water soluble surfactant having a cloud point greater than about 37° C., a second water soluble surfactant having a cloud point greater than about 37° C., wherein a mixture of the first surfactant and the second surfactant comprises a cloud point less than about 37° C.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.